Abstract
For centuries, surgeons have operated on patients in order to remove diseased tissues or to manage traumatic injuries. The objectives of practitioners of such an extirpative discipline became to minimize the surgical tissue loss or to adapt the patient to a regrettable but necessary disability. Only during the twentieth century has the focus of surgery expanded from ablation of disease and shifted toward the restoration of lost function by transplanting living and normally functioning tissues and organs from one individual to another. The success of clinical transplantation has been limited by the transplant surgeon’s understanding of the body’s immune response to transplanted tissues and by effective modulation of this response through suppression of the immune system. An understanding of the history of clinical immunosuppression enables one to understand both the limitations and the future of clinical organ transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander, J. W., Vaughn, W. K., and Pfaff, W. W., 1987, Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: An analysis of one and two years, Transplant. Proc. 19: 672–674.
Anderson, C. B., Sicardo, G. A., and Etheredge, E. E., 1982, Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products, Surgery 92: 315–321.
Billingham, R. E., Brent, L., and Medawar, P. B., 1953, Actively acquired tolerance of foreign cells, Nature (Lond.) 172: 603–606.
Borel, J. F., Feurer, C., Gubler, H. V., and Stahelin, H., 1976, Biological effects of cyclosporin A; a new antilymphocytic agent, Agents Actions 6: 468–475.
Caine, R. Y., Alexandre, G. P. J., and Murray, J. E., 1962, A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs, NY Acad. Sci. 99: 743–761.
Caine, R. Y., Rolles, K., White, D. J., Thiru, S., Evans, D. B., McMaster, P., Dunn, D. C., Craddock, G. N., Henderson, R. G., Aziz, S., and Lewis, P., 1979, Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers, Lancet 2: 1033–1039.
Canadian Multicentre Transplant Study Group, 1983, A randomized clinical trial of cyclosporin in cadaveric renal transplantation, N. Engl. J. Med. 309: 809–815.
Carrel, A., 1910, Remote results of the replantation of the kidney and the spleen, J. Exp. Med. 12: 146–150.
Cecka, J. M., Cicciarelli, J., Mickey, M. R., and Terasaki, P. I., 1988, Blood transfusions and HLA matching—an either/or situation in cadaveric renal transplantation, Transplantation 45: 81–86.
Cleary, M. L., Warnke, R., and Sklar, J., 1984, Monoclonality of lymphoproliferative in cardiac transplant recipients, N. Engl. J. Med. 310: 477–482.
Cupps, T. R., and Fauci, A. S., 1982, Corticosteroid-mediated immunoregulation in man, Immunolog. Rev. 65: 133–155.
Dupont, E., Wybran, J., and Toussaint, C., 1984, Glucocorticoids and organ transplantation, Transplantation 37: 331–335.
Elzinga, L., Kelley, V. E., Houghton, D. C., and Bennett, W. M., 1987, Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine, Transplantation 43: 271–274.
English, T. A., McGregor, C., Wallwork, J., and Cory-Pearce, R., 1982, Aspects of immunosuppression for cardiac transplantation, Heart Transplant. 1: 280–284.
European Multicentre Trial Group, 1983, Cyclosporin in cadaveric renal transplantation: One year followup of a Multicentre Trial, Lancet 2: 986–989.
Flechner, S. M., Kerman, R. H., Van Buren, C. T., and Kahan, B. D., 1984a, Successful transplantation of cyclosporine treated haploidentical living related renal recipients without blood transfusions, Transplantation 37: 73–76.
Flechner, S. M., Van Buren, C. T., Kerman, R. H., and Kahan, B. D., 1984b, The nephrotoxicity of cyclosporine in renal transplant recipients, Transplant. Proc. 15: 2689–2694.
Franksson, C., Lundgren, G., Magnusson, G., and Rigden, O., 1976, Drainage of thoracic duct lymph in renal transplant patients, Transplantation 21: 133–140.
Frazier, O. H., Macris, M. P., Duncan, J. M., Van Buren, C. T., and Cooley, D. A., 1988, Cardiac transplantation in patients over 60 years of age, Ann. Thorac. Surg. 45: 129–132.
Fuks, Z., Strober, S., Bobrove, A. M., Sasazuki, T., McMichael, A., and Kaplan, H. S., 1976, Long term effects of radiation on T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease, J. Clin. Invest. 58: 803–814.
Glassock, R. J., Feldman, D., Reynolds, E. S., Dammin, G. J., and Merrill, J. P., 1968, Human renal isografts: A clinical and pathologic analysis, Medicine (Baltimore) 47: 411–454.
Kahan, B. D., Kerman, R. H., Wideman, C. A., Flcchncr, S. M., Jarwenko, M., and Van Buren, C. T, 1985, Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston, Am. J. Kidney Dis. 5: 288–295.
Kerman, R. H., Floyd, M., Van Buren, C. T., and Kahan, B. D., 1980, Improved allograft survival of strong immune responder-high risk recipients with adjuvant ATG therapy, Transplantation 30:450–454.
Kerman, R. H., Floyd, M., Van Buren, C. T., McConnell, R., McConnell, B. J., and Kahan, B. D., 1981, Correlation of non-specific immune monitoring with rejection or impaired function of renal allografts, Transplantation 32: 16–23.
Kerman, R. H., Van Buren, C. T., Lewis, R. M., and Kahan, B. D., 1988a, Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts, Transplantation45: 37–40.
Kerman, R. H., Van Buren, C. T., Lewis, R. M., Frazier, O. H., Cooley, D., and Kahan, B. D., 1988b, The impact of HLA A,B, and DR, blood transfusions, and immune responder status on cardiac allograft recipients treated with cyclosporine, Transplantation 45: 333–337.
Kirkman, R. L., Barrett, L. V., Gaulton, G. N., Kelley, V. E., Ythier, A., and Strom, T., 1985, Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice, J. Exp. Med. 162: 358–362.
Kulkarni, S. S., Bhateley, D. C., Zander, A. P., Van Buren, C. T., Rudolph, F. B., Dicke, K. A., and Kulkarni, A. D., 1984, Functional impairment of T-lymphocytes in mouse radiation chimeras by a nucleotide free diet, Exp. Hematol. 12: 629–699.
Kulkarni, A. D., Fanslow, W. C., Rudolph, F. B., and Van Buren, C. T., 1987, Modulation of delayed hypersensitivity in mice by dietary nucleotide restriction, Transplantation 44: 847–849.
Lorber, M. I., Flechner, S. M., Van Buren, C. T., Kerman, R. H., Bartosh, J., and Kahan, B. D., 1985, Cyclosporine toxicity: The effect of combined therapy using cyclosporine, azathioprine, and prednisone, Hum. Immunol. 13: 59–60.
Lorber, M. I., Van Buren, C. T., Flechner, S. M., Williams, C., and Kahan, B. D., 1987, Hepatobiliary and pancreatic complications of cyclosporin therapy in 466 renal transplant patients, Transplantation 43: 35–40.
Matas, A. J., Tellis, V. A., Quinn, T. A., Glicklich, D., Soberman, R., and Veith, F. J., 1988, Individualization of immediate posttransplant immunosuppression, Transplantation 45: 406–409.
Merrill, J. P., Murray, J. E., Harrison, J. H., and Guild, W. R., 1956, Successful homotransplantation of the human kidney between identical twins, JAMA 160:277–282.
Murray, J. E., Merrill, J. P., Dammin, G. J., Dealy, J. B., Alexandre, G. W., and Harrison, J. H., 1962, Kidney transplantation in modified recipients, Ann. Surg. 156: 337–355.
Myers, B. D., Ross, J., Newton, L., Luetscher, J., and Perlroth, M. 1984, Cyclosporine-associated chronic nephropathy, N. Engl. J. Med. 311: 699–705.
Myburgh, J. A., Smith, J. A., Hill, R. R. H., and Browde, S., 1980, Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. I1. Renal allograft, Transplantation 29: 405–408.
Najarian, J. S., Simmons, R. L., Condie, R. M., Thompson, E. J., Fryd, D. S., Howard, R. J., Matas, A. J., Sutherland, D. E., Ferguson, R. M., and Schmidtke, J. R., 1976, Seven years experience with antilymphoblast globulin for renal transplantation, Ann. Surg. 184: 352–368.
Najarian, J. S., Ferguson, R. M., Sutherland, D. E., Slavin, S., Kim, T., Kersey, J., and Simmons, R. L.. 1982, Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation, Ann. Surg. 196: 442–452.
Najarian, J. S., Fryd, G. S., Strand, M., Canafax, D. M., Ascher, N. L., Dayne, W. D., Simmons, R. L., and Sutherland, D. E., 1985, A single-institution, randomized, prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients, Ann. Surg. 201: 142–157.
Okazaki, H., Maki, T., Wood, M., and Monoco, A. P., 1980, Effect of a single transfusion of donor specific and nonspecific blood on skin allograft survival in mice, Transplantation 30: 421–428.
Opelz, G., Sengar, D. P., Mickey, M. R., and Terasaki, P. I., 1973, Effect of blood transfusions on subsequent kidney transplants, Transplant. Proc. 5: 253–259.
Opelz, G., 1987, Improved kidney graft survival in nontransfused recipients, Transplant. Proc. 19: 149–152.
Penn, I., 1981, Depressed immunity and the development of cancer, Clin. Exp. Immunol. 46: 459–474.
Renlund, O. G., Bristow, M. R., Lybbert, M. R., O’Connell, J. B., and Gay, W. A., 1987, Medicare designated centers for cardiac transplantation, N. Engl. J. Med. 316: 873–876.
Reitz, B. A., Wallwork, J. L., Hunt, S. A., Pennock, J. L., Billingham, M. E., Oyer, P. E., Stinson, E. B., and Shumway, M. E., 1982, Heart lung transplantation: Successful therapy for patients with pulmonary vascular disease, N. Engl. J. Med. 306: 557–564.
Report of the Task Force on Organ Transplantation, 1986, Organ Transplantation: Issues and Recommendations, U. S. Department of Health and Human Services, Public Health Service, Health Resources and Services Administration, Office of Organ Transplantation, April, 1986.
Salvatierra, O., Vincenti, F., Amend, W., Potter, D., Iwaki, Y., Opelz, G., Terasaki, P., Duca, R., Cochrum, K., Hanes, D., Stoney, R., and Feduska, N., 1980, Deliberate donor-specific blood transfusions prior to living related renal transplantation, Ann. Surg. 192: 543–552.
Sampson, O., Levin, B. S., Hoppe, R. T., Bierber, C. P., Miller, E., Waer, M., Kaplan, H. S., Collins, G., and Strober, S., 1985, Preliminary observations on the use of total lymphoid irradiation, rabbit antithymocyte globulin, and low dose prednisone in human cadaver renal transplantation, Transplant. Proc. 17: 1299–1303.
Sanfilippo, F., Vaughn, W. K., Spees, E. K., Light, J., and LeFor, W. M., 1984, Benefits of HLA-A and HLA-B matching on graft and patients. Outcome after cadaver—donor renal transplantation, N. Engl. J. Med. 311: 358–364.
Schroeder, J. S., and Hunt, S. A., 1986, Cardiac transplantation: Where are we? N. Engl. J. Med. 315: 961–963.
Schwartz, R., and Dameshek, W., 1959, Drug-induced immunological tolerance, Nature (Lond.) 183: 1682–1683.
Sherlock, S., 1983, Hepatic transplantation: The state of play, Lancet 2: 778–779.
Simmons, R. L., Matas, A. J., Rattazzi, L. C., Balfour, H. H., Howard, R. J., and Najarian, J. S., 1977, Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation, Surgery 82: 537–546.
Smith, M. D., Williams, J. D., Coles, G. A., and Salaman, J.R., 1981, The effect of blood transfusion on T suppressor cells in renal dialysis patients, Transplant. Proc. 13: 181–183.
Sollinger, H. W., Stratta, R. J., Kalayoglu, M., Pirsch, J. D., and Belzer, F. O., 1987, Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression, Surgery 102: 674–679.
Spees, E. K., Vaughn, W. K., Williams, G. M., Filo, R. S., MacDonald, J. C., Mendez-Picon, G., and Niblack, G., 1980, Effects of blood transfusion on cadaver renal transplantation, Transplantation 30: 455–463.
Starzl, T. E., Marchioro, T. L., Porter, K. A., and Brettschneider, L., 1967, The liver: Homotransplantation of the liver, Transplantation 5: 790–803.
Starzl, T. E., Groth, C.G., Putnam, C. W., Corman, J., Halgrimson, C. G., Penn, I., Husberg, B., Gustafsson, A., Cascardo, S., Geis, P., and Iwatsuki, S., 1973, Cyclophosphamide for clinical renal and hepatic transplantation, Transplant. Proc. 5: 511–516.
Starzl, T. E., Iwatsuki, S., Klintmalm, G., Schroter, G. P., Weil, R., Koep, L. T., and Porter, K. A., 1981, Liver transplantation 1980, with particular reference to cyclosporin A, Transplant. Proc. 18: 281–285.
Thistlethwaite, J. R., Gaber, A. O., Haag, B. W., Aronson, A. J., Broelsch, C. E., Stuart, J. K., and Stuart, F. P., 1987, OKT3 treatment of steroid-resistant renal allograft rejection, Transplantation 43: 176–184.
Tilney, N. L., Strom, T. B., Vineyard, G. C., and Merrill, J. P., 1978, Factors contributing to the declining mortality rate in renal transplantation, N. Engl. J. Med. 299: 1321–1325.
Toronto Lung Transplant Group, 1986, Unilateral lung transplantation for pulmonary fibrosis, N. Engl. J. Med. 314: 1140–1145.
Van Buren, C. T., Kulkarni, A. D., and Rudolph, F. B., 1983a, Synergistic effect of a nucleotide-free diet and cyclosporine on allograft survival, Transplant. Proc. 15(suppl 2): 2967–2968.
Van Buren, C. T., Kulkami, A., Schandle, B. V., and Rudolph, F. B., 1983b, The influence of dietary nucleotides on cell mediated immunity, Transplantation 36: 350–352.
Van Buren, C. T., Kulkarni, A. D., Fanslow, W. C., and Rudolph, F. B., 1985, Dietary nucleotides: A requirement for helper/inducer T lymphocytes, Transplantation 40: 694–697.
Van Buren, C. T., Kim, E. E., Kulkarni, A. D., Fanslow, W. L., and Rudolph, F B.. 1987, Nucleotide free diet and suppression of the immune response, Transplant. Proc. 19: 57–59.
Watson, D. C., Reitz, B. A., Oyer, P. E., Stinson, E. B., and Shumway, N. E., 1980, Sequential orthotopic heart transplantation in man, Transplantation 30: 401–403.
Zukoski, C. F., Callaway, J. M., and Rhea, W. G., 1965, Prolonged acceptance of canine renal allograft achieved with prednisolone, Transplantation 3: 380–386.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Van Buren, C.T. (1989). Developments in Immunosuppression The Secret to the Success of Organ Transplantation . In: Kaufman, H.H. (eds) Pediatric Brain Death and Organ/Tissue Retrieval. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5532-8_23
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5532-8_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5534-2
Online ISBN: 978-1-4684-5532-8
eBook Packages: Springer Book Archive